Bellevue Group Ag Agios Pharmaceuticals, Inc. Transaction History
Bellevue Group Ag
- $6.38 Billion
- Q1 2024
A detailed history of Bellevue Group Ag transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 4,006,000 shares of AGIO stock, worth $146 Million. This represents 1.84% of its overall portfolio holdings.
Number of Shares
4,006,000
Previous 4,011,000
0.12%
Holding current value
$146 Million
Previous $89.3 Million
31.13%
% of portfolio
1.84%
Previous 1.39%
Shares
24 transactions
Others Institutions Holding AGIO
# of Institutions
207Shares Held
60MCall Options Held
365KPut Options Held
457K-
Farallon Capital Management LLC San Francisco, CA5.59MShares$203 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$202 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$169 Million0.0% of portfolio
-
State Street Corp Boston, MA3.14MShares$114 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.96MShares$108 Million1.18% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.99B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...